SCHEMBL25435575

SCHEMBL25435575

Cn1cnc(-c2nc(S(C)(=O)=O)nc(N)c2-c2cc[nH]c2)c1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 2/20 0.36
▸ LRRK2 Q5S007 1/20 0.33
▸ CYP2E1 P05181 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2B6 P20813 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KAT8 Q9H7Z6 2/20 0.33
▸ KAT5 Q92993 1/20 0.33
▸ KAT6A Q92794 2/20 0.32
▸ TLR7 Q9NYK1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31135000 0.68 LOXL2 (0.36) LOXL2LRRK2CYP2E1CYP2A6CYP2C9
SCHEMBL2187562 0.61 LRRK2 (0.42) LRRK2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL20092109 0.61 SYK (0.48) LOXL2LRRK2CYP2E1CYP2A6CYP2C9
SCHEMBL19805614 0.61 SDHB (0.67) —
SCHEMBL1302834 0.61 LOXL2 (0.50) LOXL2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL29699125 0.60 SDHB (0.34) LRRK2
SCHEMBL18806853 0.58 CYP2C9 (0.57) LOXL2LRRK2CYP2E1CYP2A6CYP2C9
SCHEMBL29091969 0.58 KDM4E (0.50) CYP2C9CYP2C19
SCHEMBL733288 0.57 LMNA (0.47) —
SCHEMBL2671981 0.57 CYP2C9 (0.51) LRRK2CYP2E1CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159307-A9 POLO-LIKE KINASE 4 (PLK4) INHIBITORS, PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF REPARE THERAPEUTICS INC. (CA) 2024-03-21 — — WO disclosed
WO-2023159307-A1 POLO-LIKE KINASE 4 (PLK4) INHIBITORS, PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF REPARE THERAPEUTICS INC. (CA) 2023-08-31 — — WO disclosed
Send feedback